Stephan Tarantolo

Learn More
Hepatic venoocclusive disease (HVOD) is a complication of allogeneic hematopoietic stem cell transplantation (HSCT) and is a well-recognized dose-limiting toxicity of oral busulfan (Bu)-based preparative regimens. The unpredictable absorption of oral Bu from the gastrointestinal (GI) tract and hepatic first-pass effects have led to the development of an(More)
BACKGROUND We present a case report of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) developing in a kidney/pancreas transplant recipient after the initiation of treatment with clopidogrel for symptomatic coronary artery disease. METHODS A 35-year-old male kidney/pancreas recipient developed unstable angina 5 years after(More)
8204 Background: Epoetin alfa (EPO) 40,000 U subcutaneously (SC) once weekly (QW) significantly reduces transfusions, increases hemoglobin (Hb), and improves overall quality of life in anemic cancer patients (pts) receiving chemotherapy (CT). Higher QW initiation doses may improve hematologic response (HR) rates by stimulating erythropoiesis, allowing less(More)
  • 1